Share on StockTwits

CSL Limited (ASX:CSL) was upgraded by equities research analysts at Deutsche Bank to a “buy” rating in a research note issued to investors on Wednesday. The firm currently has a $76.50 price objective on the stock.

Several other analysts have also recently commented on the stock. Analysts at Credit Suisse reiterated an “outperform” rating on shares of CSL Limited in a research note on Thursday, August 21st. They now have a $74.55 price target on the stock. One analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the company. CSL Limited presently has an average rating of “Buy” and an average price target of A$74.28 ($68.78).

CSL Limited (ASX:CSL) traded up 0.89% during mid-day trading on Wednesday, hitting A$74.850. The stock had a trading volume of 776,927 shares. CSL Limited has a one year low of A$63.770 and a one year high of A$74.850. The stock’s 50-day moving average is A$68.30 and its 200-day moving average is A$69.21. The company has a market cap of A$35.538 billion and a P/E ratio of 27.57.

CSL Limited is an Australia-based company. The Company is engaged in the research, development, manufacture, marketing and distribution of biopharmaceutical and allied products.

Receive News & Ratings for CSL Limited Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CSL Limited and related companies with Analyst Ratings Network's FREE daily email newsletter.